Association Between Kidney Function and Incidence of Dementia: 10-year Follow-up of the Whitehall II Cohort Study
Overview
Authors
Affiliations
Background: Cognitive dysfunction is common in haemodialysis patients but whether poor kidney function in the general population is also associated with higher risk of dementia remains unclear.
Objective: To examine the association of kidney function with incident dementia in community dwelling older adults.
Design: Whitehall II prospective study.
Setting: Population-based study on 6,050 adults, mean age 65.8 in 2007-2009.
Methods: Poor kidney function, defined as estimated Glomerular Filtration Rate (eGFR) <60 ml/min/1.73 m2 in 2007-2009, and adverse change in eGFR was defined as decrease ≥4 ml/min/1.73 m2 between 2007-2009 and 2012-2013.Incident dementia was ascertained through linkage to electronic health records, and Cox regression was used to examine associations with dementia.
Results: A total of 306 cases of dementia were recorded over a mean follow-up of 10 years. Baseline eGFR <60 was associated with a hazard ratio (HR) for dementia of 1.37 (95% CI 1.02, 1.85) in analysis adjusted for sociodemographic factors, hypertension, obesity, stroke, diabetes and cardiovascular disease/medication. Removing stroke cases at baseline and censoring them over the follow-up yielded an HR of 1.42 (95% CI 1.00, 2.00) for the association between CKD and dementia. Decline of eGFR ≥4 between 2007-2009 and 2012-2013 was associated with incidence of dementia over a 6.3 year mean follow-up (HR: 1.37; 95% CI 1.02, 1.85), with somewhat stronger associations when analyses were restricted to those with eGFR ≥60 in 2007-2009 (1.56; 95% CI: 1.12, 2.19).
Conclusion: Poor and declining kidney function in older adults is associated with a higher risk of dementia that is not attributable to stroke and persists after accounting for major cardiometabolic conditions.
Moen S, Misialek J, Hughes T, Johnson C, Sarnak M, Forrester S Kidney Med. 2025; 7(3):100961.
PMID: 39996163 PMC: 11847729. DOI: 10.1016/j.xkme.2024.100961.
Lu J, Kadier K, Dilixiati D, Qiao B, Nuer R, Zebibula A Ren Fail. 2024; 46(2):2427178.
PMID: 39581996 PMC: 11590190. DOI: 10.1080/0886022X.2024.2427178.
Establishing a machine learning dementia progression prediction model with multiple integrated data.
Huang Y, Liu T, Lu C BMC Med Res Methodol. 2024; 24(1):288.
PMID: 39578765 PMC: 11583646. DOI: 10.1186/s12874-024-02411-2.
ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes.
Fonseca L, Beeri M, Hawks Z, Jung L, Cleveland M, Delgado N Alzheimers Dement (Amst). 2024; 16(4):e70029.
PMID: 39445343 PMC: 11497176. DOI: 10.1002/dad2.70029.
Assessing Risk Factors for Cognitive Decline Using Electronic Health Record Data: A Scoping Review.
Wang L, Yang R, Sha Z, Kuraszkiewicz A, Leonik C, Zhou L Res Sq. 2024; .
PMID: 39149490 PMC: 11326370. DOI: 10.21203/rs.3.rs-4671544/v1.